High-Dose Inactivated Influenza Vaccine Linked to Lower Rates of Hospitalization in HF
Patients with heart failure who receive a high-dose inactivated influenza vaccine have a decreased risk for hospitalization.
A study in Circulation: Heart Failure found that high-dose inactivated influenza vaccine (HD-IIV) is associated with reduced rates of hospitalizations related to laboratory-confirmed influenza, cardiorespiratory disease, cardiovascular disease, and heart failure in patients with heart failure.
- The study analyzed data from the DANFLU-2 trial, conducted in Denmark over three consecutive influenza seasons (2022-2025), which included individuals aged 65 years and older.
- Participants were randomly assigned to receive either HD-IIV or standard-dose inactivated influenza vaccine (SD-IIV).
No direct quote available in the text.
Author's summary: High-dose flu vaccine reduces hospitalization rates in heart failure patients.
More News
- College And Career Fair Connects Calaveras Students To Future Opportunities - myMotherLode.com
- Flau’jae Johnson Shuts Down Governor’s Call for Charlie Kirk Statue at LSU, Social Media Rides With Her
- US and Lebanese navies complete ‘Resolute Union 26’ maritime exercise
- New exhibition connects art and ecology to a public audience
- Shares of Navan Down 16% In Long-Awaited IPO Debut
- Why Baptism Must Precede Membership and the Table | SHARPER IRON
- SAF will not make meaningful impact anytime soon
- Stranger Things 5 Trailer Unleashes All-Out War in Hawkins Ahead of Final Season! | SPIN1038
- Over £8,000 raised to support family of North Belfast man who tragically drowned on holiday in Turkey
- Bailey Anderson: Co-organizer of the Desert Biennial Project, now excerpted at the Holland Project